| Multiple | Now | Sector median | Where it sits |
|---|---|---|---|
| P/E | 31.1× | −1.7× | |
| Price / Book | 2.1× | 2.0× | |
| Price / Sales | 2.4× | 4.0× | |
| Price / Free cash flow | 19.6× | −1.6× | |
| EV / EBITDA | 14.2× | −1.2× | |
| Earnings yield | 3.2% | −14.6% | |
| Free cash flow yield | 5.1% | −9.9% |
| Company | Price | Change | Mkt cap (USD) | P/E | ROE | 1Y |
|---|---|---|---|---|---|---|
LLNYSE:LLYEli Lilly and Co · 🇺🇸 NYSE | $1,247.77 | −0.74% | $1.17T | 57.3× | 77.8% | +16.7% |
JNNYSE:JNJJohnson & Johnson · 🇺🇸 NYSE | $251.98 | −1.40% | $607.25B | 23.0× | 32.9% | +33.7% |
ABNYSE:ABBVAbbVie Inc · 🇺🇸 NYSE | $283.30 | −0.74% | $500.62B | 119.3× | −129.2% | +26.2% |
UNNYSE:UNHUnitedHealth Group Inc · 🇺🇸 NYSE | $402.00 | +0.14% | $360.83B | 29.9× | 12.8% | +11.2% |
MRNYSE:MRKMerck & Co Inc · 🇺🇸 NYSE | $144.79 | −0.79% | $357.22B | 19.7× | 34.7% |
NVNYSE:NVSNovartis AG · 🇺🇸 NYSE | $150.19 | −0.29% | $277.84B | 19.8× | 30.5% | +15.9% |
AZNYSE:AZNAstraZeneca PLC · 🇺🇸 NYSE | $165.06 | −0.21% | $255.99B | 25.0× | 21.1% | −2.2% |
TMNYSE:TMOThermo Fisher Scientific Inc · 🇺🇸 NYSE | $677.37 | −1.83% | $250.46B | 37.9× | 12.6% | +30.7% |
AMNAS:AMGNAmgen Inc · 🇺🇸 NAS | $427.30 | −1.20% | $231.01B | 30.3× | 89.1% | +45.5% |
GINAS:GILDGilead Sciences Inc · 🇺🇸 NAS | $154.70 | −0.95% | $191.82B | 22.8× | 37.5% | +32.0% |
